Delivery Order SPE2DR25D1053-SPE2DR26FT219
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,730.75 on September 25, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit quantities. This is a firm fixed-price delivery order valued at $1,344.96, with an ultimate completion date of September 22, 2025. The award is not set-aside and represents a competitive procurement of pharmaceutical products for federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.07 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (60 units) with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $23,086.01 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 60-unit quantities. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Cyclosporine 0.05% Eye Emulsion (30 units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by August 7, 2025, reflecting the expedited nature of pharmaceutical supply fulfillment to support federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,893.61 to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 30-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a $21,750.49 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-unit package). This firm fixed-price, competitively awarded contract requires delivery by September 10, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the open competition process through which it was procured. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) with a ceiling value of $2,072.32. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a $7,327.31 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal medical...
- The Defense Logistics Agency awarded a $10,114.72 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) on September 15, 2025, with a completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT219Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. This $2,744.57 firm fixed-price delivery order is scheduled for completion by October 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion vehicle valued through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across multiple agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its role in supplying essential medications and medical commodities across diverse therapeutic domains to support military and veteran healthcare systems. Through its prime IDC with DLA, the contractor provides access to specialty medications, brand-name and generic drugs, vaccines, and related medical supplies, positioning it as a key participant in the Defense Logistics Agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/22/25 |